Hochhaus A, O’Brien SG, Guilhot F, et al: Sixyear follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 23: 1054-1061, 2009
Ohe Y, Yamamoto S, Suzuki K, et al: Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer. Eur J Cancer 37: 54-63, 2001